EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial
Abstract
Authors
L. Perrier K. Zarca T. Cadet M. Morelle C. Cropet A. Burges S.C. Cecere I. Palacio S. Polterauer H. Yoshida P. Vuylsteke N. Colombo T.J. Nøttrup C. Abdeddaim A. El-Balat S. Cinieri A. Herrero M.C. Kaminski E. Pujade-Lauraine I. Durand-Zaleski I. Ray-Coquard